NPPA Revises Retail Prices Of 56 Formulations, Ceiling Price Of 2 Formulations
Mumbai, 6 July 2018: The National Pharmaceutical Pricing Authority (NPPA) has revised retail prices of 56 formulations, and ceiling price of 2 formulations under Drugs (Prices Control) Order, 2013 in a notification dated dated July 4, 2018.
Name of the formulations are Rosuvastatin + Clopidogrel Capsule (Crevast CV 20), Fluconazole Dispersible Tablet (Ultican –50 DT), Amoxycillin + Clavulante Dry Syrup (Clanoxy Forte), Telmisartan + Metoprolol Tablet(Metolar TL 50), Telmisartan + Metoprolol Tablet (Metolar TL 25), Hydroxychloroquine Sulphate Tablet (OXCQ 300mg), Glimepiride+ Metformin Tablet, Glimepiride+Metformin+ Voglibose Tablet, Telmisartan +Clinidipine+ Chlorthalidone Tablet, Clonazepam+ Propranolol Tablet, Telmisartan + Chlorthalidone Tablet (Telpha -CH), Cilnidipine +Telmisartan Tablet(Cilniblu T), Sofosbuvir + Velpatsvir Tablet, Etoricoxib + Paracetamol Tablet, Adapalene+ Benzoyl Gel, Teneligliptin+ Metformin Tablet (Walaphage T 1000), Travoprost + Timolol Eye Drops (Travisight –T), Cilnidipine + Telmisartan + Chlorthalidone Tablet, Telmisartan + Hydrochlorthiazide Tablet ( Telpha – H ), Ferrous Ascorbate + Folic Acid Tablet , Doxorubicin Hydrochloride Injection, Rosuvastation + Clopidogrel Capsule, Cilnidipine + Telmisartan Tablet (Nexovas T ), Cilnidipine + Telmisartan Tablet (Zitelmi –CL).
The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production/import and sale of scheduled formulations in Form - III of Schedule - II of the DPCO, 2013 through IPDMS.
Any manufacturer intending to discontinue production of said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form -IV of Schedule - II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.
The manufacturers not complying with the ceiling price and notes specified shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
Consequent to the issue of ceiling prices of such formulations as specified, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.Pharmabiz